4.5 Article

Acute effects of casein on postprandial lipemia and incretin responses in type 2 diabetic subjects

Journal

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
Volume 20, Issue 2, Pages 101-109

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.numecd.2009.03.019

Keywords

Type 2 diabetes; Casein; Triglyceride; Postprandial period; Incretins; Islet hormones

Ask authors/readers for more resources

Background and aims: Exaggerated and prolonged postprandial lipemia is potentially atherogenic and associated with type 2 diabetes. Limited data exist regarding the influence of dietary protein on postprandial lipemia in type 2 diabetes. We investigated, over 8-h, the acute effects of casein alone or in combination with carbohydrate on postprandial lipid and incretin responses to a fat-rich meal in type 2 diabetes. Methods and results: Eleven type 2 diabetic subjects ingested four test meals in random order: an energy-free soup plus 80 g of fat (control-meal); control-meal plus 45 g carbohydrates (CHO-meal); control-meal plus 45 g of casein (PRO-meal); and PRO-meal plus 45 g carbohydrates (CHO + PRO-meal). Triglyceride and retinyl palmitate responses were measured in plasma and in a chylomicron-rich and chylomicron-poor fraction. We found no significant differences in triglyceride responses to PRO- and CHO + PRO-meal compared to the control-meal. However, the addition of casein to the CHO-meal reduced the raised triglyceride response in the chylomicron-rich fraction. Retinyl palmitate responses did not differ significantly between meals in the chylomicron-rich fraction, whereas the PRO-meal increased retinyl palmitate in the chylomicron-poor fraction. PRO- and PRO + CHO-meal increased insulin and glucagon compared to the control-meal. PRO + CHO-meal increased the glucose-dependent insulinotropic peptide response while no change in glucagon-like peptide-1 responses was detected. Conclusions: The data presented suggest that casein per se did not modulate the postprandial triglyceride response in type 2 diabetes. When added to carbohydrate, casein suppressed the triglyceride response in the chylomicron-rich fraction, increased insulin and glucagon but did not affect the incretin responses. (C) 2009 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Cardiac & Cardiovascular Systems

Cardiovascular effects of incretins: focus on glucagon-like peptide-1 receptor agonists

Sten Madsbad, Jens J. Holst

Summary: GLP-1 receptor agonists (GLP-1 RAs) are effective in treating type 2 diabetes and promoting weight loss. Different GLP-1 RAs have varying efficacy in reducing blood sugar, body weight, and cardiovascular events. Some GLP-1 RAs are recommended for patients with established cardiovascular diseases or multiple cardiovascular risk factors. Cardiovascular outcome trials (CVOT) provide guidance for individual treatment decisions.

CARDIOVASCULAR RESEARCH (2023)

Article Endocrinology & Metabolism

The naturally occurring GIP(1-30)NH2 is a GIP receptor agonist in humans

Liva S. L. Krogh, Kristine Henriksen, Signe Stensen, Kirsa Skov-Jeppesen, Natasha C. Bergmann, Joachim Storling, Mette M. Rosenkilde, Bolette Hartmann, Jens J. Holst, Laerke S. Gasbjerg, Filip K. Knop

Summary: The effects of GIP(1-30)NH2 on glucose and bone metabolism in humans and in isolated human pancreatic islets are similar to those of GIP(1-42).

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2023)

Article Endocrinology & Metabolism

Gastrointestinal hormones and appetite ratings after weight loss induced by diet or bariatric surgery

Marthe Isaksen Aukan, Silje Skarvold, Ingrid Ofsti Brandsaeter, Jens Frederik Rehfeld, Jens Juul Holst, Siren Nymo, Silvia Coutinho, Catia Martins

Summary: This study aimed to compare changes in gastrointestinal hormones and appetite ratings after weight loss induced by a very low-energy diet alone or in combination with sleeve gastrectomy (SG) or Roux-en-Y gastric bypass (RYGB). The results showed that SG and RYGB led to more significant changes in gastrointestinal hormones compared with diet alone, while appetite ratings decreased in all groups.

OBESITY (2023)

Article Endocrinology & Metabolism

Glucose metabolism, gut-brain hormones, and acromegaly treatment: an explorative single centre descriptive analysis

Nanna Thurmann Jorgensen, Trine Moller Erichsen, Morten Buus Jorgensen, Thomas Idorn, Bo Feldt-Rasmussen, Jens J. Holst, Ulla Feldt-Rasmussen, Marianne Klose

Summary: The purpose of this study was to investigate the effects of different treatment regimens on glucose, insulin, glucagon, GLP-1, and GIP secretion in patients with active acromegaly. The results showed that treatment with SSA impaired GIP response and other hormone responses. Co-treatment with PEG increased insulin and glucagon secretion compared to treatment with SSA alone. PEG may exert its action through GH-receptors on pancreatic delta-cells.

PITUITARY (2023)

Article Endocrinology & Metabolism

Acarbose diminishes postprandial suppression of bone resorption in patients with type 2 diabetes

Niels B. Dalsgaard, Laerke S. Gasbjerg, Mads M. Helsted, Laura S. Hansen, Nina L. Hansen, Kirsa Skov-Jeppesen, Bolette Hartmann, Jens J. Holst, Tina Vilsboll, Filip K. Knop

Summary: In patients with type 2 diabetes, treatment with acarbose reduces the postprandial suppression of bone resorption, possibly due to increased secretion of the gut hormone GLP-1. The impairment of bone resorption suppression caused by acarbose may be partially reversed by GLP-1 receptor antagonism. Additionally, acarbose-induced reductions in other factors, such as glucose-dependent insulinotropic polypeptide, may also contribute to this phenomenon.
Article Cardiac & Cardiovascular Systems

Combination of exercise and GLP-1 receptor agonist treatment reduces severity of metabolic syndrome, abdominal obesity, and inflammation: a randomized controlled trial

Rasmus M. Sandsdal, Christian R. Juhl, Simon B. K. Jensen, Julie R. Lundgren, Charlotte Janus, Martin B. Blond, Mads Rosenkilde, Adrian F. Bogh, Lasse Gliemann, B. Jensen Jens-Erik, Charalambos Antoniades, Bente M. Stallknecht, Jens J. Holst, Sten Madsbad, Signe S. Torekov

Summary: This study investigated the effects of exercise, a GLP-1 RA, or the combination on metabolic syndrome severity, abdominal obesity, and inflammation. The findings suggest that exercise, liraglutide treatment, or the combination can reduce the risk of cardiovascular disease and type 2 diabetes, as well as decrease the severity of metabolic syndrome, abdominal obesity, and inflammation.

CARDIOVASCULAR DIABETOLOGY (2023)

Article Endocrinology & Metabolism

Liraglutide changes postprandial responses of gut hormones involved in the regulation of gallbladder motility

Henriette H. Nerild, Andreas Bronden, Ida M. Gether, Pernille H. Hellmann, Mille Baekdal, Matthew P. Gillum, Jens S. Svenningsen, Bolette Hartmann, Naveen Rathor, Hanna Angelene Kudiyanur Muniraju, Jens F. Rehfeld, Jens J. Holst, Tina Vilsboll, David P. Sonne, Filip K. Knop

Summary: In this study, it was found that Liraglutide treatment is associated with gallbladder-related disorders and can delay postprandial gallbladder refilling. The gut hormones CCK, FGF19, and GLP-2, which regulate gallbladder motility, may be implicated in these disorders.

DIABETES OBESITY & METABOLISM (2023)

Review Endocrinology & Metabolism

The expanding incretin universe: from basic biology to clinical translation

Daniel J. Drucker, Jens J. Holst

Summary: Incretin hormones, such as GIP and GLP-1, play a crucial role in regulating insulin secretion and glucagon secretion. The receptors for these hormones are not only found in the pancreas but also in various other organs, suggesting a wide range of actions. The therapeutic potential of GIP and GLP-1 in treating type 2 diabetes and obesity is currently being explored.

DIABETOLOGIA (2023)

Editorial Material Medicine, General & Internal

Childhood Obesity at the Crossroads of Science and Social Justice

David S. Ludwig, Jens J. Holst

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2023)

Article Biochemistry & Molecular Biology

Glucagon 100 years. Important, but still enigmatic

Jens Juul Holst

Summary: Glucagon was discovered as a contaminant of early insulin preparations in 1923 and its hormonal nature was established in the 1950s with the development of radioimmunoassay. Its role in hepatic glucose production and diabetic hyperglycemia has been recognized, but there are still unresolved issues regarding the measurement of glucagon and its extrapancreatic sources.

PEPTIDES (2023)

Article Biochemical Research Methods

Protocol to assess arteriovenous differences across the liver and hindlimb muscles in mice following treadmill exercise

Stephen P. Ashcroft, Sara L. Jepsen, Amy M. Ehrlich, Jonas T. Treebak, Jens J. Holst, Juleen R. Zierath

Summary: This study introduces a protocol to investigate the release and uptake of metabolites in specific tissues during exercise. It includes steps for treadmill running of mice and sampling of blood from the liver and hindlimb muscles, providing insights into tissue-specific metabolism.

STAR PROTOCOLS (2023)

Article Endocrinology & Metabolism

Effects of a Low-Carbohydrate-High-Protein Pre-Exercise Meal in Type 1 Diabetes-a Randomized Crossover Trial

Kasper B. Kristensen, Ajenthen G. Ranjan, Olivia M. McCarthy, Jens J. Holst, Richard M. Bracken, Kirsten Norgaard, Signe Schmidt

Summary: A low-carbohydrate-high-protein (LCHP) pre-exercise meal can reduce plasma glucose variability around exercise and diminish the drop in plasma glucose over exercise compared to a high-carbohydrate-low-protein (HCLP) meal.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2023)

Article Biochemistry & Molecular Biology

Post-prandial secretion of glucagon-like peptide-2 (GLP-2) after carbohydrate-, fat- or protein enriched meals in healthy subjects

August Pilegaard Prahm, Mark Krogh Hvistendahl, Christopher Filtenborg Brandt, Paul Blanche, Bolette Hartmann, Jens Juul Holst, Palle Bekker Jeppesen

Summary: This study compared the effects of three iso-energetic meals with different macronutrient compositions on postprandial secretion of GLP-2, PYY, and GIP. The results showed that a high protein meal had the highest stimulatory effect on GLP-2 and PYY secretion, while a high carbohydrate meal was most effective for GIP.

PEPTIDES (2023)

Article Multidisciplinary Sciences

Hepatic Glucose Production, Ureagenesis, and Lipolysis Quantified using the Perfused Mouse Liver Model

Marie Winther-Sorensen, Ida Marie Kemp, Hanne Cathrine Bisgaard, Jens Juul Holst, Nicolai J. Wewer Albrechtsen

Summary: The isolated perfused liver allows study of liver biology and metabolism, separated from external factors, and can be used to evaluate the direct effects of compounds on the liver.

JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2023)

Article Endocrinology & Metabolism

Increased Insulin Secretion and Glucose Effectiveness in Obese Patients with Type 2 Diabetes following Bariatric Surgery

Roberto Visentin, Katrine Brodersen, Bjorn Richelsen, Niels Moller, Chiara Dalla Man, Andreas Kristian Pedersen, Jan Abrahamsen, Jens Juul Holst, Michael Festersen Nielsen

Summary: The early improvement in glucose tolerance in obese T2D patients after bariatric surgery is mainly due to increased insulin secretion and glucose effectiveness, with insulin sensitivity playing a minor role.

JOURNAL OF DIABETES RESEARCH (2023)

No Data Available